Atb Cap Markets Comments on OTC:GTBIF FY2025 Earnings

Green Thumb Industries Inc. (OTC:GTBIF) – Equities researchers at Atb Cap Markets dropped their FY2025 earnings estimates for Green Thumb Industries in a note issued to investors on Monday, December 9th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings of $0.14 per share for the year, down from their previous forecast of $0.15. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share.

GTBIF has been the subject of a number of other reports. Roth Capital upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research report on Sunday, November 10th. Craig Hallum raised shares of Green Thumb Industries to a “strong-buy” rating in a report on Monday, September 16th.

Green Thumb Industries Stock Performance

OTC:GTBIF opened at $8.00 on Tuesday. The company’s fifty day moving average is $9.73. The company has a market cap of $1.69 billion, a price-to-earnings ratio of 29.63 and a beta of 1.31. Green Thumb Industries has a 52-week low of $7.50 and a 52-week high of $16.33.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.